vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Xometry, Inc. (XMTR). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $192.4M, roughly 1.1× Xometry, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -4.5%, a 7.2% gap on every dollar of revenue. On growth, Xometry, Inc. posted the faster year-over-year revenue change (29.5% vs 27.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-5.9M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 25.2%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Xometry is an online marketplace for sourcing on-demand manufactured parts for prototyping and large-scale production.
IRTC vs XMTR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $192.4M |
| Net Profit | $5.6M | $-8.6M |
| Gross Margin | 70.9% | 39.1% |
| Operating Margin | 1.1% | -4.6% |
| Net Margin | 2.7% | -4.5% |
| Revenue YoY | 27.1% | 29.5% |
| Net Profit YoY | 518.5% | 12.7% |
| EPS (diluted) | $0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $192.4M | ||
| Q3 25 | $192.9M | $180.7M | ||
| Q2 25 | $186.7M | $162.5M | ||
| Q1 25 | $158.7M | $151.0M | ||
| Q4 24 | $164.3M | $148.5M | ||
| Q3 24 | $147.5M | $141.7M | ||
| Q2 24 | $148.0M | $132.6M | ||
| Q1 24 | $131.9M | $122.7M |
| Q4 25 | $5.6M | $-8.6M | ||
| Q3 25 | $-5.2M | $-11.6M | ||
| Q2 25 | $-14.2M | $-26.4M | ||
| Q1 25 | $-30.7M | $-15.1M | ||
| Q4 24 | $-1.3M | $-9.9M | ||
| Q3 24 | $-46.2M | $-10.2M | ||
| Q2 24 | $-20.1M | $-13.7M | ||
| Q1 24 | $-45.7M | $-16.6M |
| Q4 25 | 70.9% | 39.1% | ||
| Q3 25 | 71.1% | 39.9% | ||
| Q2 25 | 71.2% | 40.1% | ||
| Q1 25 | 68.8% | 37.3% | ||
| Q4 24 | 70.0% | 39.7% | ||
| Q3 24 | 68.8% | 39.4% | ||
| Q2 24 | 69.9% | 39.9% | ||
| Q1 24 | 66.3% | 39.0% |
| Q4 25 | 1.1% | -4.6% | ||
| Q3 25 | -4.4% | -6.1% | ||
| Q2 25 | -10.0% | -6.3% | ||
| Q1 25 | -20.5% | -10.2% | ||
| Q4 24 | -2.5% | -7.8% | ||
| Q3 24 | -34.1% | -8.1% | ||
| Q2 24 | -15.5% | -11.5% | ||
| Q1 24 | -28.9% | -14.6% |
| Q4 25 | 2.7% | -4.5% | ||
| Q3 25 | -2.7% | -6.4% | ||
| Q2 25 | -7.6% | -16.3% | ||
| Q1 25 | -19.3% | -10.0% | ||
| Q4 24 | -0.8% | -6.7% | ||
| Q3 24 | -31.3% | -7.2% | ||
| Q2 24 | -13.6% | -10.3% | ||
| Q1 24 | -34.6% | -13.5% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.97 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-1.48 | — | ||
| Q2 24 | $-0.65 | — | ||
| Q1 24 | $-1.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $219.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $275.6M |
| Total Assets | $1.0B | $703.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $219.1M | ||
| Q3 25 | $565.2M | $224.5M | ||
| Q2 25 | $545.5M | $225.8M | ||
| Q1 25 | $520.6M | $231.4M | ||
| Q4 24 | $535.6M | $239.8M | ||
| Q3 24 | $522.0M | $234.0M | ||
| Q2 24 | $561.5M | $240.9M | ||
| Q1 24 | $569.1M | $253.8M |
| Q4 25 | $152.7M | $275.6M | ||
| Q3 25 | $121.9M | $272.0M | ||
| Q2 25 | $103.7M | $270.4M | ||
| Q1 25 | $86.7M | $309.9M | ||
| Q4 24 | $90.9M | $314.5M | ||
| Q3 24 | $71.8M | $315.2M | ||
| Q2 24 | $99.2M | $315.8M | ||
| Q1 24 | $90.3M | $320.4M |
| Q4 25 | $1.0B | $703.7M | ||
| Q3 25 | $995.2M | $698.9M | ||
| Q2 25 | $964.0M | $687.0M | ||
| Q1 25 | $926.1M | $690.1M | ||
| Q4 24 | $931.4M | $680.1M | ||
| Q3 24 | $909.7M | $678.2M | ||
| Q2 24 | $919.2M | $678.6M | ||
| Q1 24 | $909.8M | $692.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $4.4M |
| Free Cash FlowOCF − Capex | $14.5M | $-5.9M |
| FCF MarginFCF / Revenue | 6.9% | -3.0% |
| Capex IntensityCapex / Revenue | 5.6% | 5.3% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-24.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $4.4M | ||
| Q3 25 | $34.9M | $5.8M | ||
| Q2 25 | $27.7M | $-427.0K | ||
| Q1 25 | $-7.9M | $-3.7M | ||
| Q4 24 | $19.2M | $9.1M | ||
| Q3 24 | $24.3M | $-3.6M | ||
| Q2 24 | $11.8M | $-9.1M | ||
| Q1 24 | $-52.0M | $-11.7M |
| Q4 25 | $14.5M | $-5.9M | ||
| Q3 25 | $20.1M | $-1.7M | ||
| Q2 25 | $17.3M | $-7.4M | ||
| Q1 25 | $-17.3M | $-9.2M | ||
| Q4 24 | $12.4M | $4.5M | ||
| Q3 24 | $15.5M | $-8.4M | ||
| Q2 24 | $3.4M | $-13.5M | ||
| Q1 24 | $-61.8M | $-16.1M |
| Q4 25 | 6.9% | -3.0% | ||
| Q3 25 | 10.4% | -0.9% | ||
| Q2 25 | 9.3% | -4.5% | ||
| Q1 25 | -10.9% | -6.1% | ||
| Q4 24 | 7.5% | 3.1% | ||
| Q3 24 | 10.5% | -6.0% | ||
| Q2 24 | 2.3% | -10.2% | ||
| Q1 24 | -46.8% | -13.1% |
| Q4 25 | 5.6% | 5.3% | ||
| Q3 25 | 7.7% | 4.1% | ||
| Q2 25 | 5.6% | 4.3% | ||
| Q1 25 | 5.9% | 3.6% | ||
| Q4 24 | 4.2% | 3.1% | ||
| Q3 24 | 6.0% | 3.4% | ||
| Q2 24 | 5.7% | 3.3% | ||
| Q1 24 | 7.4% | 3.5% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
XMTR
| US | $159.1M | 83% |
| Non Us | $33.3M | 17% |
